# FDA recall Z-1744-2018

> **Hyphen BioMed** · Class II · device recall initiated 2018-02-05.

## Product

ZYMUTEST HIA IgGAM; REF Number: RK040D; UDI: 03663537018770 a qualitative screening assay intended for the global detection of heparin- dependent antibodies, whether the isotype is: IgG, IgM and IgA, in human plasma, by clinical laboratories.

## Reason for recall

Incorrect package insert indicating use of the kits with plasma, serum, and other biological fluids. The kits should only be used with plasma.

## Distribution

OH, MD, NC, NY, NH, Canada, Sweden

## Key facts

- **Recall number:** Z-1744-2018
- **Recalling firm:** Hyphen BioMed
- **Classification:** Class II
- **Product type:** device
- **Status:** Terminated
- **Initiation date:** 2018-02-05
- **Report date:** 2018-05-16
- **Termination date:** 2018-08-16

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Neuville Sur Oise, N/A, France

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1744-2018

## Citation

> AI Analytics. FDA recall Z-1744-2018. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/Z-1744-2018. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*